Objectives To define the pattern of fetal echocardiographic changes associated with isolated pulmonary valve stenosis (PS) 
INTRODUCTION
Pulmonary valve stenosis (PS) accounts for 8-10% of congenital heart defects (CHD) and represents the second most common CHD in postnatal life 1 . It can occur as a part of a more complex anomaly or as an isolated finding, most commonly at valvular level. The presentation of isolated PS depends on its severity. In the fetus, the greatest impact of PS is on the developing right ventricle (RV), with a continuum ranging from normal RV growth to RV hypoplasia and dysfunction. The incidence of isolated PS in fetal life is considerably lower than that postnatally, which may reflect underdiagnosis of mild PS during pregnancy and/or its progression in the third trimester.
Most information on PS in fetal life focuses on critical PS and on pulmonary atresia with intact interventricular septum, which represent the most severe manifestations of this condition. Efforts have been directed towards identifying echocardiographic parameters that predict a biventricular postnatal outcome [2] [3] [4] [5] [6] . However, there is very limited information regarding the fetal cardiovascular morphometric and functional changes associated with PS 7 , especially in its milder forms. Such information may be valuable to understand better the progression of PS during fetal life, and consequently to improve prenatal counseling and planning of postnatal management.
In this study, we report a prospective series of 16 fetuses affected by isolated PS, being mainly mild and moderate cases diagnosed in the third trimester of pregnancy. The aims of our study were: (1) to define the pattern of fetal echocardiographic changes associated with isolated PS; and (2) to correlate the echocardiographic findings with neonatal outcome and the need for postnatal pulmonary valvuloplasty within the first 12 months postpartum.
METHODS
We recruited prospectively from January 2009 to October 2015 fetuses with isolated PS and antegrade flow through the pulmonary valve at diagnosis, regardless of the direction of flow in the ductus arteriosus, from a consecutive series of 1500 fetuses with CHD evaluated in the Fetal Cardiology Unit at BCNatal (Barcelona). The unit operates as a referral center for pregnancies at high risk for CHD. Baseline and postnatal data were collected from the medical records. PS was defined by the presence of pulmonary valve dysplasia (valve hyperechogenicity, thickening and/or hypomobility) combined with systolic flow acceleration (peak velocity > 140 cm/s). PS was subclassified as: critical (presence of reversed flow in the ductus arteriosus any time before delivery); moderate (RV hypertrophy with significant tricuspid regurgitation (TR)); or mild (the remainder). Fetuses with pulmonary atresia or additional cardiac defects were excluded. Cases were compared with gestational-age (GA)-matched controls (± 2 weeks) using a 3:1 control:case ratio, GA being calculated based on the crown-rump length at first-trimester ultrasound 8 . Controls were recruited from consecutive uncomplicated pregnancies during the same study period. The study was approved by the institutional ethics committee. Written informed consent was obtained from all mothers.
Maternal age, smoking status, parity, hypertension, diabetes and perinatal outcome, including GA, delivery mode, birth weight and Apgar score, were recorded.
All women underwent ultrasonographic examination using a Siemens Sonoline Antares (Siemens Medical Systems, Malvern, PA, USA) ultrasound machine. Doppler and echocardiographic evaluations were performed using a curved-array 2-6-MHz transducer, with the exception of tissue Doppler measurements, which required a phased-array 2-10-MHz transducer. Structural fetal ultrasound encompassed a detailed extracardiac and cardiac examination, following recommended guidelines [9] [10] [11] . Standard obstetric ultrasound comprised estimation of fetal weight (EFW), measurement of umbilical artery pulsatility index (PI), fetal middle cerebral artery PI, ductus venosus PI and aortic isthmus PI [12] [13] [14] . EFW was calculated according to the method of Hadlock et al. 15 . EFW centile was calculated using institutional reference curves 16 . The cerebroplacental ratio was calculated by dividing the middle cerebral artery PI by the umbilical artery PI 17 . Fetal cardiac morphometry included measurement of cardiac area, atrial areas, ventricular diameters and myocardial free-wall and septal thickness from an apical or transverse four-chamber view. All measurements were obtained at end-diastole, with the exception of atrial areas, which were taken at the maximum point of atrial distension at end-systole.
Evaluation of systolic function included heart rate (HR), ejection fraction, RV and left ventricle (LV) stroke volumes (SV), RV and LV cardiac output (CO), combined cardiac output (CCO), mitral (MAPSE) and tricuspid (TAPSE) annular-plane systolic excursion and peak systolic annular velocities (S ). HR was calculated from spectral Doppler interrogation of pulmonary flow. LV and RV ejection fractions were obtained from a transverse four-chamber view on M-mode, using Teicholz's formula 18 . LV-SV and RV-SV were calculated as π/4 × (aortic or pulmonary valve diameter) 2 × (aortic or pulmonary artery systolic flow velocity-time integral). Aortic systolic flow was obtained in an apical or basal five-chamber view of the heart and pulmonary artery systolic flow in a RV outflow tract view, both at angles as close to 0
• as possible. Velocity-time integrals were calculated by manual trace of the spectral Doppler area under the curve. Diameters of the aortic and pulmonary valves were measured during systole by the leading edge-to-edge method at the valve ring level 19 . LV-CO and RV-CO were calculated as LV-SV or RV-SV × fetal HR. CCO was obtained by addition of right and left CO and expressed in mL/min/kg 20 . MAPSE and TAPSE were assessed by M-mode in an apical or basal four-chamber view, by placing the cursor at a right angle to the atrioventricular junction, marked by the valve rings at the mitral or tricuspid valves 21 ; maximum amplitude of motion was taken as the extent of displacement between end-systole and end-diastole, measured in millimeters. Tissue Doppler imaging was applied in spectral Doppler mode at mitral lateral, septal and tricuspid lateral annuli from an apical or basal four-chamber view, to record S in cm/s 22 .
Fetal diastolic function was evaluated by peak early (E) and late (A) transvalvular filling velocities, E/A ratio and early (E ) and late (A ) diastolic annular peak velocities. Atrioventricular flow velocities were obtained from a basal or apical four-chamber view, placing the pulsed Doppler sample volume just below the valve leaflets 23 . Pulsed tissue Doppler imaging was applied at the mitral and tricuspid lateral annuli, from an apical or basal four-chamber view, to record E and A in cm/s 22 . Fetal cardiac-timing measurements included ventricular inflow and ejection time and left myocardial performance index (MPI). Inflow duration for RV and LV, respectively, was measured from tricuspid and mitral spectral Doppler early diastolic (E)-wave onset to later diastolic (A)-wave termination. RV and LV ejection times, respectively, were measured using Doppler interrogation of pulmonary and aortic systolic flows. To account for HR differences between groups, all timing measurements were normalized to the duration of the cardiac cycle and expressed as a percentage of the mean cardiac cycle duration of the three cardiac cycles analyzed. Left MPI was obtained in a cross-section of the fetal thorax in the four-chamber view, as described previously 24 . Briefly, isovolumetric contraction (ICT) and relaxation (IRT) times and ejection time were measured using the mitral and aortic valves 'clicks' as landmarks and MPI was calculated using the equation: MPI = (ICT + IRT)/ejection time.
Subjects were followed until 12 months postnatally. Admission to the intensive care unit, days of hospitalization, need for prostaglandins and surgery (type and age at surgery) were reviewed. PS subjects were reclassified postnatally into critical, moderate or mild PS according to the peak systolic pressure gradient across the pulmonary valve and/or the presence of impaired RV function on echocardiography 25 . PS cases were further analyzed according to need for postnatal valvuloplasty within the first 12 postnatal months.
Statistical analysis
Data were analyzed using the IBM SPSS Statistics for Windows statistical package (version 21, IBM Corp., Armonk, NY, USA). The Kolmogorov-Smirnov test was used to confirm normal distribution of the variables. Data are presented as mean ± SD or n (%). Comparisons between groups were made with Student's t-test or chi-square test, as appropriate. P < 0.05 was considered statistically significant.
RESULTS

Baseline, prenatal and postnatal characteristics
The initial study population consisted of 19 fetuses with isolated PS and antegrade flow through the pulmonary valve at diagnosis, evaluated at the Fetal Cardiology Unit at BCNatal. Of these, two were lost to follow-up and one was excluded due to postnatal diagnosis of a 3-mm apical ventricular septal defect. Thus, we analyzed 16 singleton fetuses with isolated PS, diagnosed mainly in the third trimester of pregnancy (median GA at diagnosis, 33.4 (range, 20.0-36.5) weeks). These were compared with 48 GA-matched controls (1:3 case:control ratio). Baseline, standard fetal ultrasound and perinatal characteristics are shown in Table 1 . The study groups were similar in maternal age, parity and smoking status. None of the cohort experienced pregnancy-related complications such as pre-eclampsia, intrauterine growth restriction or gestational diabetes. All newborns had an appropriate birth weight for GA and none presented major neonatal complications. EFW and obstetric Doppler studies were similar between the groups. Table 2 details prenatal and postnatal cardiac characteristics of the 16 fetuses with PS. Most fetuses had mild or moderate PS, with only three fetuses having reversed flow in the ductus arteriosus. As expected, pulmonary artery peak systolic velocity was significantly higher in the PS group compared with controls (205.1 ± 102.4 vs 76.3 ± 12.3 cm/s, P < 0.001). All cases showed signs of pulmonary valve dysplasia and 6/16 (37.5%) cases presented significant TR. Only five cases were diagnosed before 24 weeks of gestation (Table 2) . In this subgroup, although Cases 14-16 were classified initially as moderate PS due to the presence of significant TR at diagnosis, they were finally reclassified as critical PS because of the appearance of reversed flow in the ductus arteriosus in the third trimester. Severity of PS prenatally correlated well with that postnatally. Only two infants were reclassified postnatally, according to the peak systolic pressure gradient across the pulmonary valve: from mild to moderate PS (Cases 10 and 13). Prostaglandin administration was started in four of the 16 newborns; in Cases 14-16, the treatment was indicated based on a pulmonary gradient > 64 mmHg, whereas in Case 11 it was started because of the presence of impaired RV function with severe TR at echocardiography. Although most fetuses in our series had mild PS prenatally, it is noteworthy that six newborns underwent postnatal pulmonary valvuloplasty, and half of these were cases with antegrade flow in the ductus arteriosus at fetal echocardiography (Cases 11-13).
Fetal cardiac morphometric and functional results
Results of cardiac morphometry and function are shown in Table 3 . Compared with controls, fetuses with PS had significantly larger and more globular hearts, with increased wall thickness, especially in the RV. PS fetuses had preserved RV ejection fraction, ejection time and systolic longitudinal motion, but signs of increased RV preload, with a higher tricuspid A-wave velocity and significant TR in 37.5% of the cases. RV adaptation to the increased preload was suggested by increased RV-SV and RV-CO. Regarding LV function, PS fetuses showed increased LV radial and longitudinal motion, as shown by a higher ejection fraction and MAPSE, a non-significant trend towards higher SV and CO values and a significantly 
Data shown as mean ± SD, mean or n (%). *Student's t-test. GA, gestational age; NICU, neonatal intensive care unit; PI, pulsatility index; US, ultrasound. PS infants were reclassified postnatally, according to peak systolic pressure gradient across pulmonary valve, into mild (< 36 mmHg), moderate (36-64 mmHg) and critical (> 64 mmHg or functional pulmonary atresia with reversed flow in ductus arteriosus (DA)). echo, echocardiography; GA, gestational age; PA, pulmonary artery; PG, prostaglandin; PSV, peak systolic velocity; TR, tricuspid regurgitation.
prolonged ejection time. The mitral A-wave velocity was also increased in PS compared with controls. These findings possibly reflect increased right-to-left shunting through the fossa ovalis. Finally, PS fetuses showed signs consistent with biventricular diastolic dysfunction, reflected by increased ductus venosus PI and E/E ratios compared with controls.
Possible predictors of postnatal pulmonary valvuloplasty
A subanalysis was performed within the 16 fetuses with PS in order to identify prenatal differences in the echocardiographic parameters between those fetuses requiring and those not requiring postnatal pulmonary valvuloplasty. As shown in Table 3 , fetuses requiring postnatal pulmonary valvuloplasty had a significantly smaller RV ( Figure 1 ) and pulmonary valve diameter, with reduced RV longitudinal systolic function (decreased TAPSE), but similar cardiac size, biventricular wall thickness and RV-CO to those which did not undergo valvuloplasty. LV-CO and mitral A-wave velocity were considerably increased in the group of fetuses requiring postnatal valvuloplasty, while LV longitudinal and radial systolic function were preserved. However, fetuses requiring postnatal valvuloplasty showed more pronounced signs of LV diastolic dysfunction, with decreased mitral E peak velocity (Table 3 , Figure 2 ). Data are shown as mean ± SD. All cardiac morphometric measurements were performed at end-diastole, with exception of atria, which were measured at end-systole. *Student's t-test: PS vs controls. †Student's t-test between PS subgroups: valvuloplasty vs no valvuloplasty. ‡Wall thickness asymmetry calculated as septal-/free-wall thickness. §Ejection and inflow times adjusted by cardiac cycle duration. A, late transvalvular filling peak velocity; A , late diastole annular peak velocity; E, early transvalvular filling peak velocity; E , early diastole annular peak velocity; LA, left atrium; LV, left ventricle; MAPSE, mitral annular plane systolic excursion; PI, pulsatility index; RA, right atrium; RV, right ventricle; S , systolic annular peak velocity; TAPSE, tricuspid annular plane systolic excursion.
DISCUSSION
This study describes fetal cardiac structural and functional changes associated with PS in a unique prenatal cohort including mainly mild to moderate cases. The main findings were increased myocardial thickness and diastolic dysfunction, affecting not only the RV but also the LV. We also identified several fetal echocardiographic signs that may potentially predict the need for postnatal pulmonary valvuloplasty in affected fetuses. Our series differs substantially from those of previous studies, which included mainly fetuses with critical PS and pulmonary atresia [2] [3] [4] [5] [6] . Most of our cases had a severity of PS thought to be associated with a favorable prognosis, and all subjects ultimately achieved a biventricular outcome. Nonetheless, despite having mainly mild/moderate PS during fetal life, a substantial number (six of 16, including three which were classified as mild or moderate prenatally) required pulmonary valvuloplasty postnatally. Consistent with the potentially clinically important impact of PS, even at the relatively mild severity in our series, we found several signs of RV remodeling and adaptation to increased afterload, associated with the need for postnatal intervention. The RV adapts to chronically increased afterload by hypertrophy and by adopting a more spherical configuration in order to generate higher force and pressure 26, 27 . The lack of RV dilatation, preserved systolic indices and elevated RV-CO suggest adequate adaptation. Nonetheless, the effects of hypertrophy and possibly myocardial dysfunction were manifested by parameters of decreased compliance and diastolic dysfunction. In postnatal RV pressure-load, the development of reduced RV compliance and diastolic dysfunction may precede systolic dysfunction 28, 29 . Diastolic dysfunction may persist even after relief of RV pressure overload, possibly due to development of fibrosis 30 . Whether the significantly elevated RV-CO in the PS group, a presumed adaptive mechanism, may contribute to RV dysfunction, possibly through increased volume loading, remains unknown. 
LV morphometry and function in pulmonary valve stenosis
While the literature has focused almost exclusively on the impact of PS on the RV, we found that morphometric and functional findings extended to the LV. PS fetuses had higher LV filling velocities and increased radial and longitudinal LV systolic function. We postulate that these occurred secondary to an increased right-to-left shunt across the fossa ovalis and increased LV volume loading. It is notable that LV wall thickness was greater and that LV ejection time was prolonged in the PS group. Moreover, fetuses with PS showed signs of LV diastolic dysfunction, as demonstrated by a higher mitral E/E ratio. Although the underlying pathophysiologic mechanisms were not delineated by our study, adverse RV-LV and diastolic temporal interactions are emerging as determinants of LV dysfunction and prognosis in postnatal conditions of increased RV pressure-loading such as in pulmonary arterial hypertension 31 . Altered timing of RV free-wall contraction leading to RV-LV systolic discoordination and systolic and diastolic septal dyskinesia are present in children with pulmonary hypertension in association with reduced RV efficiency and impaired LV filling, but is far less prominent in children with PS 32 . While the mechanisms in the fetus remain unknown, our findings suggest that even mild or moderate PS affects the LV, possibly through increased right-to-left flow at the atrial level. Direct RV to LV interactions may also play a role and require further study.
Association with postnatal pulmonary valvuloplasty
Although the number of subjects who underwent postnatal pulmonary valvuloplasty was too small to draw strong conclusions, we found that, compared with those not requiring intervention postnatally, fetuses requiring postnatal pulmonary valvuloplasty presented with increased prenatal biventricular remodeling, a smaller RV, smaller pulmonary valve diameter, decreased longitudinal systolic function, reduced mitral E velocity and increased LV-CO. These data are consistent with the findings of a recent study conducted in 129 neonates with pulmonary atresia and critical PS undergoing pulmonary valvuloplasty within the first 2 weeks postpartum 33 . That study reported global transient LV dysfunction following neonatal pulmonary valvuloplasty in 35% of the patients, which normalized within 10 days. Although the causes of LV dysfunction are not known, the authors postulate that it may occur secondary to acute changes in LV volume loading after pulmonary valvuloplasty. A smaller pulmonary valve diameter, increased RV apical area and more than moderate TR were predictors of LV dysfunction, implying adverse RV-LV interactions.
Finally, during the study period, 80 children were referred to our cardiology unit with a postnatal diagnosis of PS before 12 months of age (39 corresponding to critical PS and 41 to milder forms). Our data suggest not only that identification of the less severe forms of PS can be difficult in fetal life, but also that milder forms of PS probably develop during pregnancy and manifest only in the third trimester or even in the first months of postnatal life. However, when possible, prenatal identification is valuable in order to coordinate better postnatal management. In this sense, while, generally, emphasis is placed on the direction of ductal arteriosus flow, we have identified other echocardiographic parameters that may predict the need for postnatal intervention in fetuses with PS. In our series, three of the six fetuses requiring postnatal pulmonary valvuloplasty had antegrade flow in the ductus arteriosus before delivery. Thus, it appears that antegrade ductal flow does not exclude subsequent need for valvuloplasty. It has also been demonstrated recently that fetuses with pulmonary atresia or severe PS, with retrograde flow in the ductus arteriosus, in association with various CHD, showed decreased PI in the distal pulmonary vasculature 34 , which suggests capacity of the fetal pulmonary vasculature to adapt in response to anatomical obstruction to flow. Larger studies may confirm the utility of new echocardiographic and Doppler parameters to risk-stratify patients and better inform them on postnatal management strategies.
Strengths and limitations of the study
Our study contained a unique cohort of fetuses with predominantly mild or moderate PS, providing potential novel and useful information for counseling parents. Most of our cases were diagnosed in the third trimester of pregnancy, with only five cases diagnosed before 24 weeks of gestation. This probably reflects local proficiency in cardiac scanning of referring physicians and the use of third-trimester ultrasound, which may not apply to other settings. The RV-CO results should be interpreted with caution since we measured the pulmonary diameter at the valve ring instead of at the level of the valve tips. The number of subjects who underwent postnatal pulmonary valvuloplasty was small, limiting the conclusions that can be drawn regarding the potential correlation between prenatal echocardiography and postnatal outcome. Future studies, including a larger cohort of fetuses with longer postnatal follow-up, are required to confirm our results. The relatively novel cardiac-cycle timing and interventricular interaction parameters explored in this study also warrant further investigation in larger series.
In conclusion, our study demonstrates that even mild or moderate PS induces cardiovascular remodeling in fetal life. Fetuses with PS presented with more hypertrophic, larger and globular hearts in the third trimester of pregnancy, associated with a higher right CO and impaired biventricular relaxation. In addition, signs of increased LV contraction were observed. Our data suggest that RV and LV functional parameters could be useful for predicting the need for postnatal pulmonary valvuloplasty and provide further insight into the pathophysiological response of the fetal RV to increased afterload.
